Over 30 million psychedelic users in the United States
Teri Suzanne Krebs, Pål-ørjan Johansen
F1000Research March 28, 2013 DOI: 10.12688/f1000research.2-98.v1 via OpenAlex
Summary
AI-generated from the abstractIn 2010, about 32 million people in the United States had used psychedelics such as LSD, psilocybin, mescaline, or peyote at least once in their lives. Among those aged 21 to 64, 17% reported lifetime use, with 22% of males and 12% of females. The highest rate of use occurred in people aged 30 to 34, where 20% had used psychedelics, including 26% of men and 15% of women. These estimates come from a national survey of 57,873 individuals aged 12 and older.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 57,873 |
| Population | US individuals aged 12 years and older |
| Keywords | Open peer review Plant biology Physiology Medicine Neuroscience |
| Citations | 125 |
| Key finding | In 2010, approximately 32 million US residents had used psychedelics in their lifetime, with the highest prevalence among people aged 30 to 34. |
Abstract
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).